These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36552969)

  • 1. Quantitative Susceptibility Mapping: Translating an Investigative Research Tool into High Volume Clinical Diagnostic Imaging.
    Borzage MT; Doyle EK; Liu CJ; Nelson MD; Blüml S; Wood JC; Tamrazi B
    Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEPIA-Susceptibility mapping pipeline tool for phase images.
    Chan KS; Marques JP
    Neuroimage; 2021 Feb; 227():117611. PubMed ID: 33309901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.
    Wang Y; Spincemaille P; Liu Z; Dimov A; Deh K; Li J; Zhang Y; Yao Y; Gillen KM; Wilman AH; Gupta A; Tsiouris AJ; Kovanlikaya I; Chiang GC; Weinsaft JW; Tanenbaum L; Chen W; Zhu W; Chang S; Lou M; Kopell BH; Kaplitt MG; Devos D; Hirai T; Huang X; Korogi Y; Shtilbans A; Jahng GH; Pelletier D; Gauthier SA; Pitt D; Bush AI; Brittenham GM; Prince MR
    J Magn Reson Imaging; 2017 Oct; 46(4):951-971. PubMed ID: 28295954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism.
    Lin F; Prince MR; Spincemaille P; Wang Y
    Recent Pat Biotechnol; 2019; 13(2):90-113. PubMed ID: 30556508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ironsmith: An automated pipeline for QSM-based data analyses.
    Zachariou V; Bauer CE; Powell DK; Gold BT
    Neuroimage; 2022 Apr; 249():118835. PubMed ID: 34936923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-centre and multi-vendor reproducibility of a standardized protocol for quantitative susceptibility Mapping of the human brain at 3T.
    Lancione M; Bosco P; Costagli M; Nigri A; Aquino D; Carne I; Ferraro S; Giulietti G; Napolitano A; Palesi F; Pavone L; Pirastru A; Savini G; Tagliavini F; Bruzzone MG; Gandini Wheeler-Kingshott CAM; Tosetti M; Biagi L;
    Phys Med; 2022 Nov; 103():37-45. PubMed ID: 36219961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron quantification in basal ganglia using quantitative susceptibility mapping in a patient with ALS: a case report and literature review.
    Ghaderi S; Batouli SAH; Mohammadi S; Fatehi F
    Front Neurosci; 2023; 17():1229082. PubMed ID: 37877011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T.
    Ippoliti M; Adams LC; Winfried B; Hamm B; Spincemaille P; Wang Y; Makowski MR
    J Magn Reson Imaging; 2018 Nov; 48(5):1410-1420. PubMed ID: 29659131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
    Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
    Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease.
    Yao J; Morrison MA; Jakary A; Avadiappan S; Chen Y; Luitjens J; Glueck J; Driscoll T; Geschwind MD; Nelson AB; Villanueva-Meyer JE; Hess CP; Lupo JM
    Neuroimage; 2023 Jan; 265():119788. PubMed ID: 36476567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-centre, multi-vendor reproducibility of 7T QSM and R
    Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT
    Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
    Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.
    Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y
    J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: The impact of echo time and the potential of histogram analysis.
    Lancione M; Cencini M; Costagli M; Donatelli G; Tosetti M; Giannini G; Zangaglia R; Calandra-Buonaura G; Pacchetti C; Cortelli P; Cosottini M
    Neuroimage Clin; 2022; 34():102989. PubMed ID: 35303599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of quantitative susceptibility mapping in diagnosis of tuberous sclerosis complex and assessment of associated brain injuries at 1.5 Tesla.
    Zhang L; Xue H; Chen T; Tian H; Wang X; Wei X; Zhang H; Ma H; Ren Z
    J Clin Transl Res; 2020 Apr; 5(3):102-108. PubMed ID: 32617425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative susceptibility mapping (QSM) of the cardiovascular system: challenges and perspectives.
    Aimo A; Huang L; Tyler A; Barison A; Martini N; Saccaro LF; Roujol S; Masci PG
    J Cardiovasc Magn Reson; 2022 Aug; 24(1):48. PubMed ID: 35978351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Lin H; Wei H; He N; Fu C; Cheng S; Shen J; Wang B; Yan X; Liu C; Yan F
    Eur Radiol; 2018 Aug; 28(8):3494-3504. PubMed ID: 29470640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.
    Tiepolt S; Rullmann M; Jochimsen TH; Gertz HJ; Schroeter ML; Patt M; Sabri O; Barthel H
    Eur J Radiol; 2020 Oct; 131():109243. PubMed ID: 32916411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
    Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
    Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.